0001681622falseSalt Lake CityUtah00016816222024-12-202024-12-20

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  ___________________________________
FORM 8-K
 ___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 20, 2024
  ___________________________________
VAREX IMAGING CORPORATION
(Exact name of registrant as specified in its charter)
 ___________________________________
Delaware
(State or other jurisdiction of incorporation or organization)
001-37860
81-3434516
(Commission File Number)
(I.R.S. Employer
Identification Number)
1678 S. Pioneer Road, Salt Lake City, Utah
84104
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (801) 972-5000
Not Applicable
(Former name or former address, if changed since last report)
 ___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common StockVREXThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 1.01    Entry into a Material Definitive Agreement.

On December 20, 2024, Varex Imaging Corporation (the “Company”) completed its previously announced private offering of $125 million aggregate principal amount of its 7.875% Senior Secured Notes due 2027 (the “Additional Notes”) to initial purchasers for resale to qualified institutional buyers under Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to persons outside the United States pursuant to Regulation S under the Securities Act.

The Company intends to use the estimated $124 million of net proceeds from the offering of the Additional Notes to (i) pay the fees and expenses related to the offering and (ii) fund the partial repayment of the $200 million aggregate principal amount of the Convertible Notes on their maturity date on June 1, 2025 or the repurchase of Convertible Notes prior to their maturity date. The net proceeds of the offering were deposited (which are net of the related offering fees and expenses) into a restricted account with such proceeds solely being used to repay or repurchase the Convertible Notes.

The Additional Notes were issued pursuant to the Indenture, dated as of September 30, 2020, by and among the Company, the guarantors party thereto (the “Guarantors”), and Wells Fargo Bank, National Association, a national banking association, as trustee and as collateral agent (the “Base Indenture”), as supplemented by a Supplemental Indenture, dated as of December 20, 2024, by and among the Company, the Guarantors, and Computershare Trust Company, N.A., in its capacity as trustee and notes collateral agent (as successor to Wells Fargo Bank, National Association) (the “Supplemental Indenture,” and together with the Base Indenture, the “Indenture”). A description of the Base Indenture is included in the Company Form 8-K filed on October 1, 2020, which such description is incorporated herein.

The Additional Notes were issued as additional notes under the Indenture and are part of the same issue as the Company’s previously issued $300 million aggregate principal of 7.875% senior secured notes due 2027 (the “Existing Notes”), of which $243 million is currently outstanding. Other than their issuance date, offering price and first interest payment date, the Additional Notes have the same terms as the Existing Notes.

The above summary of the Supplemental Indenture and the Additional Notes does not purport to be complete and is qualified in its entirety by reference to the Supplemental Indenture and the Additional Notes, copies of which are filed as Exhibits 4.1 and 4.2, hereto, respectively, and incorporated by reference herein.

Item 1.02    Termination of a Material Definitive Agreement

On April 26, 2024, the Company entered into a secured delayed draw term loan credit agreement (the “Equipment Credit Agreement”), providing for a secured equipment credit facility of up to $20.0 million. . The Company has not utilized this equipment credit facility, and following the consummation of the offering of the Additional Notes, the Company intends to terminate the Equipment Credit Agreement.

Item 2.03    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth above in Item 1.01 is incorporated by reference into this Item 2.03.

Item 8.01    Other Events

On December 23, 2024, the Company issued a press release announcing the closing of the offering of the Additional Notes. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

Forward-Looking Statements

Some of the statements in this Form 8-K are “forward-looking” and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These “forward-looking” statements relate to the use of proceeds from the offering of the Additional Notes and the Company’s intent to terminate the Equipment Credit Agreement. These statements involve risks and uncertainties that may cause results to differ materially from the statements set forth in this Form 8-K. The forward-looking statements in this Form 8-K speak only as of the date of this Form 8-K and are subject to uncertainty and changes, including those contained in the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2024 filed on November 19, 2024 with the Securities and Exchange Commission (the “SEC”) and subsequent filings with the SEC. Given these circumstances, you should not place undue reliance on these forward-looking statements. Varex expressly disclaims any obligation or undertaking to release publicly any updates or revisions to such forward-looking statements to


reflect any change in its expectations with regard thereto or any changes in the events, conditions or circumstances on which any such statement is based.

Item 9.01    Financial Statements and Exhibits.
(d) Exhibits.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

VAREX IMAGING CORPORATION
Dated: December 23, 2024
By:/s/ KIMBERLEY E. HONEYSETT
Kimberley E. Honeysett
Senior Vice President, Chief Legal Officer and Corporate Secretary


Execution Version

FIRST SUPPLEMENTAL INDENTURE
First Supplemental Indenture, dated as of December 20, 2024 (this “Supplemental Indenture”), among Varex Imaging Corporation, a Delaware corporation (the “Company”), the Guarantors listed on the signature pages hereto (collectively, the “Guarantors”), and Computershare Trust Company, N.A., in its capacity as trustee (as successor to Wells Fargo Bank, National Association, in its capacity as trustee) (in such capacity, the “Trustee”) and in its capacity as notes collateral agent (as successor to Wells Fargo Bank, National Association, in its capacity as notes collateral agent) (in such capacity, the “Notes Collateral Agent”).
W I T N E S S E T H
WHEREAS, each of the Company and the Guarantors has heretofore executed and delivered to Wells Fargo Bank, National Association, as trustee and as notes collateral agent, an indenture, dated as of September 30, 2020 (the “Base Indenture”, and, as supplemented by this Supplemental Indenture, the “Indenture”), providing for the issuance of $300,000,000 aggregate principal amount of 7.875% Senior Secured Notes due 2027 (the “Existing Notes”);
WHEREAS, the Base Indenture provides that the Company may create and issue Additional Notes (as defined under the Base Indenture) under the Indenture that rank pari passu with the Existing Notes subject to compliance with Section 2.01 and Section 4.09 of the Base Indenture;
WHEREAS, the Company wishes to issue an additional $125,000,000 aggregate principal amount of 7.875% Senior Secured Notes due 2027 as Additional Notes under the Indenture (the “New Notes”) with the terms as set forth in this Supplemental Indenture;
WHEREAS, pursuant to Section 9.01(a)(1) of the Base Indenture, the Trustee, the Notes Collateral Agent, the Guarantors and the Company are authorized to amend the Base Indenture to cure any mistake, ambiguity, defect or inconsistency, without the consent of any Holder;
WHEREAS, pursuant to Section 9.01(a)(6) of the Base Indenture, the Trustee, the Notes Collateral Agent, the Guarantors and the Company are authorized to amend the Base Indenture to provide for the issuance of Additional Notes (as defined therein) in accordance with the limitations set forth in the Base Indenture, without the consent of any Holder;
WHEREAS, on the date hereof, the net proceeds received by the Company from the issuance of the New Notes shall be used solely as set forth in Section 3 herein;
WHEREAS, the Company and the Guarantors are authorized to execute and deliver this Supplemental Indenture;
WHEREAS, the Company requested that the Trustee and the Notes Collateral Agent each execute and deliver this Supplemental Indenture; and
WHEREAS, all conditions and requirements necessary to the execution and delivery of this Supplemental Indenture have been done and performed, and the execution and delivery hereof has been in all respects authorized.
1

NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders as follows:
1.Capitalized Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Base Indenture. The words “herein,” “hereof” and “hereby” and other words of similar import used in this Supplemental Indenture refer to this Supplemental Indenture as a whole and not to any particular section hereof.
2.Issuance of New Notes.
(a)Amount of New Notes. The aggregate principal amount of New Notes to be authenticated and delivered under this Supplemental Indenture on December 20, 2024 is $125,000,000.
(b)Terms of New Notes. The New Notes shall be issued as Additional Notes under the Indenture and shall:
(1)be issued as part of the same series of Existing Notes previously issued under the Base Indenture, rank pari passu with the Existing Notes, and the New Notes and the Existing Notes shall form a single class for all purposes under the Indenture, including, without limitation, waivers, amendments, redemptions and offers to purchase;
(2)be issued on December 20, 2024 at a purchase price of 101.500% of the principal amount, plus accrued and unpaid interest from October 15, 2024 to, but excluding, December 20, 2024 in the amount of $1,777,343.75; Interest on the New Notes will be payable, in cash in arrears, on April 15 and October 15 of each year, with an initial payment for the New Notes on April 15, 2025;
(3)be issuable in whole in the form of one or more Global Notes to be held by DTC and in the form, including appropriate transfer restriction legends, provided in Exhibit A of the Base Indenture; and
(4)in the case of the New Notes sold under (x) Rule 144A, bear the CUSIP number of 92214X AC0 and ISIN number of US92214XAC02, and, (y) Regulation S of the Securities Act, initially bear the CUSIP number of U9219X AB8 and ISIN number of USU9219XAB83; provided, that, promptly following the expiration of the Distribution Compliance Period for the New Notes, the Company intends to cause the beneficial interests in the New Notes in the form of the Temporary Regulation S Global Note (CUSIP number of U9219X AB8 and ISIN number of USU9219XAB83) to be exchanged for beneficial interests in the New Notes in the form of the Permanent Regulation S Global Note (CUSIP number of U9219X AA0 and ISIN number of USU9219XAAA01) in accordance with applicable law and other terms of the Indenture.
(c)Authentication of New Notes. The Trustee shall, pursuant to an Authentication Order delivered in accordance with Section 2.02 of the Indenture, authenticate and deliver the New Notes for an aggregate principal amount specified in such Authentication Order.    
3.Use of Proceeds from the New Notes.
(a)The Company agrees and covenants that the gross proceeds received by the Company from the issuance of the New Notes, which excludes the amount of pre-issuance accrued interest, will solely be used by the Company to (1) pay the fees and expenses related to the issuance of the New Notes and (2) fund the repayment of a portion of the outstanding 4.000% convertible senior unsecured notes due 2025 on their maturity date or the repurchase a portion of outstanding 4.000% convertible senior unsecured notes due 2025 prior to their maturity date, and may not be used for any purpose other than as
2

set forth in this Section 3 (such gross proceeds, less the amount set forth in clause (1), the “Net Proceeds”).
(b)The Company agrees and covenants that the Net Proceeds received by the Company shall be deposited on the date hereof into a segregated, restricted securities account (the “Restricted Account”) that was established and maintained with and, subject to the Intercreditor Agreement (as defined under the Base Indenture), exclusively controlled by Zions Bancorporation, N.A. DBA Zions First National Bank, as administrative agent (the “Administrative Agent”). As of the date hereof, the Restricted Account will be subject to the terms of an account control agreement, dated as of December 20, 2024 (the “Restricted Account Control Agreement”), by and among the Company, Zions Bancorporation, N.A., DBA Zions First National Bank, as custodian, the Administrative Agent and Computershare Trust Company, N.A., solely in its capacity as Notes Collateral Agent. The Company agrees and covenants that the Net Proceeds received by the Company from the issuance of the New Notes will be held in the Restricted Account and invested by the Company as provided therein.
4.Amendment to Definition of “Non-Guarantor Subsidiaries”.
(a)    The definition of “Non-Guarantor Subsidiaries” in the Base Indenture is hereby amended by amending and restating such definition in its entirety to read as follows:
“Non-Guarantor Subsidiaries” means (x) any Unrestricted Subsidiary and (y) any Subsidiary of the Company that does not guarantee the Company’s Obligations under the ABL Credit Agreement or any other Indebtedness of the Company or a Guarantor of $25.0 million or more. The Board of Directors of the Company may designate any Restricted Subsidiary as a Non-Guarantor Subsidiary by filing with the Trustee a certified copy of a resolution of such Board of Directors giving effect to such designation and an Officer’s Certificate certifying as to the applicable clause of the definition of Non-Guarantor Subsidiaries that warrants such designation.
5.Ratification of Indenture; Supplemental Indenture Part of Indenture; Reaffirmation of the Guarantees and the Security Documents.
(a)    Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect.
(b)    This Supplemental Indenture shall form a part of the Indenture for all purposes, and every holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby. The Trustee and the Notes Collateral Agent make no representation or warranty, and neither the Trustee nor the Notes Collateral Agent shall be responsible in any manner whatsoever, with respect to (i) the validity or sufficiency of this Supplemental Indenture or any of the terms or provisions hereof, (ii) the proper authorization hereof by the Company or Guarantors or otherwise, (iii) the due execution hereof by the Company or the Guarantors and/or (iv) the consequences (direct or indirect and whether deliberate or inadvertent) of any amendment herein provided for, and neither the Trustee nor the Notes Collateral Agent makes any representation with respect to any such matters. The recitals contained herein may be taken as the statements of the Company, and the Trustee and the Notes Collateral Agent do not assume any responsibility for their correctness. The Trustee accepts and the Notes Collateral Agent consents to the amendments effected by this Supplemental Indenture, but only upon the conditions set forth in the Indenture and Exhibit A attached to the Indenture, including the terms and provisions defining and limiting the liabilities and responsibilities of the Trustee and Notes Collateral Agent, as the case may be,
3

which terms and provisions shall in like manner define and limit their liabilities and responsibilities in the performance of the terms created by the Indenture and Exhibit A attached to the Indenture, as hereby amended.
(c)    Each Guarantor reaffirms its Guarantee set forth in Article 10 of the Base Indenture with regard to the New Notes. The Company and each Guarantor confirm that the existing security interests granted by such parties in favor of the Notes Collateral Agent, on behalf of itself, the Trustee and the Holders under the Security Documents shall continue to secure the Obligations under the Notes (including the New Notes), the Guarantees, the Indenture and the Security Documents to the extent provided for therein. The obligations of the Company and the Guarantors under this Supplemental Indenture and the New Notes shall be secured as provided in the Security Documents, and the holders of the Additional Notes shall be Notes Secured Parties.
6.Effectiveness. This Supplemental Indenture shall be effective and operative upon the Company, the Guarantors, the Trustee, the Notes Collateral Agent and the holders of the Notes immediately upon execution and delivery thereof by the parties hereto.
7.Successors. This Supplemental Indenture shall be binding on the Company, the Guarantors, the Notes Collateral Agent, the Trustee and the Holders and their respective successors and assigns and shall inure to the benefit of such parties and their respective successors and assigns.
8.Governing Law. THIS SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.
9.Waiver of Jury Trial. EACH OF THE COMPANY, THE GUARANTORS, THE NOTES COLLATERAL AGENT AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE BASE INDENTURE, THE NOTES, THE GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.
10.Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. This Supplemental Indenture shall be valid, binding, and enforceable against a party only when executed and delivered by an authorized individual on behalf of the party by means of (i) any electronic signature permitted by the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions Act, and/or any other relevant electronic signatures law, including relevant provisions of the Uniform Commercial Code/UCC (collectively, “Signature Law”); (ii) an original manual signature; or (iii) a faxed, scanned, or photocopied manual signature. Each electronic signature or faxed, scanned, or photocopied manual signature shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original manual signature. Each party hereto shall be entitled to conclusively rely upon, and shall have no liability with respect to, any faxed, scanned, or photocopied manual signature, or other electronic signature, of any party and shall have no duty to investigate, confirm or otherwise verify the validity or authenticity thereof. This Supplemental Indenture may be executed in any number of counterparts, each of which shall be deemed to be an original, but such counterparts shall, together, constitute one and the same instrument. For avoidance of doubt, original manual signatures shall be used for execution or indorsement of writings when required under the UCC or other Signature Law due to the character or intended character of the writings.
4

11.Severability. In case any one or more of the provisions in this Supplemental Indenture or in the Notes shall be held invalid, illegal or unenforceable, in any respect for any reason, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions shall not in any way be affected or impaired thereby, it being intended that all of the provisions hereof shall be enforceable to the full extent permitted by law.
12.Headings. The headings of the sections of this Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part of this Supplemental Indenture and shall in no way modify or restrict any of the terms or provisions hereof.
[Signatures appear on the following page]


5

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.
VAREX IMAGING CORPORATION
By:             
    Name: David Van Woerkom
    Title: Treasurer
VAREX IMAGING WEST, LLC
By:             
    Name: David Van Woerkom
    Title: Treasurer
VIRTUAL MEDIA INTEGRATION, LLC
By:             
    Name: David Van Woerkom
    Title: Treasurer
VAREX IMAGING DEUTSCHLAND AG
By: /s/ Marcus Kirchhoff    
    Name: Marcus Kirchhoff
    Title: Member of the Management Board
VAREX IMAGING INVESTMENTS B.V.
By:             
    Name: Kimberley E. Honeysett
    Title: Managing Director
VAREX IMAGING AMERICAS CORPORATION
By:             
    Name: David Van Woerkom
    Title: Treasurer

[Varex – Signature Page to Supplemental Indenture]

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.
VAREX IMAGING CORPORATION
By: /s/ David Van Woerkom    
    Name: David Van Woerkom
    Title: Treasurer
VAREX IMAGING WEST, LLC
By: /s/ David Van Woerkom    
    Name: David Van Woerkom
    Title: Treasurer
VIRTUAL MEDIA INTEGRATION, LLC
By: /s/ David Van Woerkom    
    Name: David Van Woerkom
    Title: Treasurer
VAREX IMAGING DEUTSCHLAND AG
By:             
    Name: Marcus Kirchhoff
    Title: Member of the Management Board
VAREX IMAGING INVESTMENTS B.V.
By: /s/ Kimberley E. Honeysett    
    Name: Kimberley E. Honeysett
    Title: Managing Director
VAREX IMAGING AMERICAS CORPORATION
By: /s/ David Van Woerkom    
    Name: David Van Woerkom
    Title: Treasurer


[Varex – Signature Page to Supplemental Indenture]

VAREX IMAGING HOLDINGS, INC.
By: /s/ Kimberley E. Honeysett    
    Name: Kimberley E. Honeysett
    Title: Vice President and Secretary
VAREX IMAGING WEST HOLDINGS, INC.
By:     /s/ David Van Woerkom    
    Name: David Van Woerkom
    Title: Treasurer
[Varex – Signature Page to Supplemental Indenture]

COMPUTERSHARE TRUST COMPANY, N.A.,
as Trustee
By: /s/ Nancy Chouanard    
    Name: Nancy Chouanard
    Title: Vice President
COMPUTERSHARE TRUST COMPANY, N.A.,
as Notes Collateral Agent
By: /s/ Nancy Chouanard    
    Name: Nancy Chouanard
    Title: Vice President



[Varex – Signature Page to Supplemental Indenture]

image.jpg
NEWS
FOR IMMEDIATE RELEASE

VAREX ANNOUNCES CLOSING OF PRIVATE OFFERING OF
$125 MILLION OF SENIOR SECURED NOTES

SALT LAKE CITY, December 23, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced it has closed its private offering (the “Offering”) of $125 million aggregate principal amount of 7.875% senior secured notes due 2027 (the “notes”) at an offering price of 101.5% of the principal amount thereof, plus accrued interest from and including October 15, 2024.

“We are pleased to have successfully closed the offering of additional senior secured notes”, said Sam Maheshwari, Chief Financial Officer of Varex Imaging Corporation. “The additional funds allow us to address the partial repayment of our convertible notes coming due in June 2025, while preserving availability under our revolving credit facility,” added Maheshwari.

Additional information concerning the notes is disclosed in Varex’s Form 8-K filed today, December 23, 2024.

No Offer or Solicitation
Nothing contained herein shall constitute an offer to sell or the solicitation of an offer to buy any security. The notes were offered and sold to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States pursuant to Regulation S under the Securities Act. The notes have not been and will not be registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Varex
Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 75 year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose, protect and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,300 people located in North America, Europe, and Asia. For more information visit vareximaging.com.

Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements concerning the use of proceeds raised in the offering to partially repay existing convertible notes due in June 2025, preserving availability under our revolving credit agreement. Any statements using the terms “intend,” “subject to,” “plan,” “will,” “may”, or similar statements are forward-looking statements that involve risks and uncertainties that could cause Varex’s actual results to differ materially from those anticipated. While forward-looking statements are based on assumptions and analyses made by us that we believe to be reasonable under the circumstances, whether actual results and developments will meet our expectations and

1678 S. Pioneer Road | Salt Lake City, UT 84104 | 801.972.5000

image.jpg
NEWS
FOR IMMEDIATE RELEASE
predictions depend on a number of risks and uncertainties which could cause our actual results, performance, and financial condition to differ materially from our expectations. Such risks and uncertainties include changes to our plans; reduction in or loss of business of one or more of our limited OEM customers; loss of business to, and an inability to effectively compete with competitors; market erosion or loss of customers due to pricing pressures and other factors; failure to meet customers’ needs and demands; economic instability, shifting political environments, changing tax treatment, reactionary import/export regulatory regimes, and other risks associated with doing business internationally; supply chain disruptions; inability to maintain or defend intellectual property rights, and the high cost of protecting such rights and defending against infringement claims; disruption of critical information systems or material security breaches of such systems; non-compliance with product-related regulations and delays in obtaining regulatory clearances or approvals; limitations imposed by operating and financial restrictions of our debt financing agreements; and the other risks listed from time to time in our filings with the U.S. Securities and Exchange Commission, which by this reference are incorporated herein. Any forward-looking statement made by us in this news release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. Varex assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

Information regarding the factors that could cause results to differ can be found in the company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2024, as well as the company’s other filings with the Securities and Exchange Commission. These forward-looking statements are based on information as of the date of this release. The company assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized.


# # #

For Information Contact:
Christopher Belfiore
Director of Investor Relations
Varex Imaging Corporation
801.973.1566 | investors@vareximaging.com

1678 S. Pioneer Road | Salt Lake City, UT 84104 | 801.972.5000
v3.24.4
Cover Cover
Dec. 20, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Dec. 20, 2024
Entity Registrant Name VAREX IMAGING CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-37860
Entity Tax Identification Number 81-3434516
Entity Address, Address Line One 1678 S. Pioneer Road, Salt Lake City, Utah
Entity Address, City or Town Salt Lake City
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84104
City Area Code 801
Local Phone Number 972-5000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol VREX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001681622
Amendment Flag false
Varex Imaging (NASDAQ:VREX)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Varex Imaging.
Varex Imaging (NASDAQ:VREX)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Varex Imaging.